Former CFO David Johnston was a seasoned finance professional, renowned author, and blogger with a strong focus on biotechnology and finance. He has written articles for reputable online businesses and medical sites such as Medium, Tumblr, the Buckeye Business Review, and DrBioScience. 

His professional journey in life sciences began in 1998 when he assumed the role of Senior Vice President of Corporate Finance, Corporate Planning, and Analysis for Genzyme, a Cambridge-based biotech company later acquired by Sanofi. After this successful stint at Genzyme, he took on the CFO position for two Boston-based multinational corporations focused on finding a cure for cancer. Before joining the biotech industry, he worked in financial roles across various industries.

David has repeatedly been recognized for his exceptional financial and strategic insight, which he currently utilizes as a consultant at dbj Consulting. His expertise lies in leading Initial Public Offerings, creative non-dilutive royalty financing, advising companies on strategic stock buy and sell solutions, managing SEC reporting and financial analysis, investor relations, corporate finance, strategic planning, and setting Key Performance Indicators (KPIs), financial modeling, mergers, and acquisitions, advising startups on fundraising, corporate development, acquisition integration, revenue recognition, due diligence, the Sarbanes-Oxley Act, developing capital allocation strategies, improving operational efficiencies through bottleneck analysis, and helping businesses make informed financial decisions.

Johnston's vast knowledge and experience have made him stand out in the fast-paced world of biotechnology and finance. Through his written work and consulting services, he has contributed immensely to the growth and success of many businesses in these sectors.